Sarnoff Chosen by Global Animal Management to Develop the First Portable Equine Iris Capture and Identification System
September 15, 2009
Sarnoff Corporation today announced it has been selected by Global Animal Management, Inc. (GAM) to develop the first portable equine iris capture and identification system to help identify and track horses.
Based on Sarnoff’s Iris on the Move® (IOM) technology, the system will quickly capture a horse’s iris image with a low visibility infrared light source from a distance, even while the animal is moving. In this way, the horse is not disturbed or unnecessarily stressed as is common using today’s methods of identification which often involve tattooing and manually checking marks on horses.
“In the high stakes sport of horse racing, correctly identifying horses is not nearly as fast or simple as it needs to be,” said Mark Clifton, Vice President, Products and Services at Sarnoff Corporation. “It can take more than a half hour to check a horse’s tattoos and markings, or even longer if they’ve faded over time, plus they’re easy to fake. Sarnoff’s new portable equine Iris ID system, based on decades of vision systems expertise and research, allows users to quickly and accurately identify horses right before a race, without undue stress on the animal.”
Sarnoff’s IOM is a proven and extensively tested biometric identification system that is currently deployed in several secure government facilities and private corporations. The technology is ideal for a wide variety of uses in addition to equine identification, including banking ID verification, border initiatives, event security, payment systems, and employee access.
For more information, visit Sarnoff at the 2009 Biometrics Consortium Conference, September 22-24, Booth #505, or on the web.
About Sarnoff Corporation
Sarnoff Corporation delivers vision, video and semiconductor technology innovations that empower government and commercial clients to see/sense, understand and control complex environments. Founded in 1942 as RCA Laboratories, Sarnoff makes continuous breakthroughs in real-time video processing for defense, security and surveillance; ICs, lasers, imaging and sensing devices; high throughput iris recognition for identity verification and access control; end-to-end video solutions. Sarnoff is a subsidiary of SRI International.
About Global Animal Management, Inc. (GAM)
GAM offers products and services for individual or group animal identification, storage, processing, analysis and reporting. GAM was the first company to have USDA interim-approved identification database with electronic ear tags approved by the NAIS. GAM is a wholly owned subsidiary of Intervet/Schering-Plough Animal Health.
To learn more about GAM, visit its website at www.mygamonline.com.
About Intervet/Schering-Plough Animal Health
Intervet/Schering-Plough Animal Health is a leader in research and dedicated to the development, production and marketing of innovative, high-quality animal-health products for all major farm and companion animal species. For more information about Intervet/Schering-Plough Animal Health visit: www.intervet.com and www.intervetusa.com.
Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough’s vision is to “Earn Trust, Every Day” with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, New Jersey, USA, and its website is www.schering-plough.com.”
SCHERING-PLOUGH DISCLOSURE NOTICE: The information in this press release includes certain “forward-looking statements” within the meaning of the private Securities Litigation Reform Act of 1995, including statements related to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough’s forward-looking statements, including market forces, economic factors, product availability, patent and other intellectual property protection, current and future branded, generic or over-the-counter competition, the regulatory process, and any developments following regulatory approval, among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough’s Securities and Exchange Commission filings, including Part II, Item 1A “Risk Factors” in the Company’s second Quarter 2009 10-Q, filed July 24, 2009.
